Find trials
Search tips

Circulating Tumor DNA in Endometrial Cancer

Overview

About this study

The goal of this study is to identify circulating tumor DNA in the preoperative blood samples of endometrial cancer patients and detect changes in the quantity and tumor-specific mutations and chromosomal rearrangements in circulating tumor DNA of patients with endometrial cancer.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Women with a pathologic diagnosis of endometrial cancer
  • Able to provide informed consent.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Andrea Mariani, M.D., M.S.

Closed for enrollment

Contact information:

Marla Kay Sommerfield

(507)538-7977

Sommerfield.Marla-Kay@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20306506

Mayo Clinic Footer